More Than a Partnership: How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive Research
Upal Basu RoyIt has been just over a year since we reported how oncogene-driven patient advocacy groups are disrupting the research paradigm in lung cancer.1 We have indeed come a long way […] Read more
Transbronchial Microwave Ablation of Malignant Lung Nodules: Outcomes, Challenges, and Perspective
Joyce W.Y. Chan+more
With increasing availability of CT scans and strong evidence for the utility of low-dose CT screening in high-risk populations,1 an increasing number of small lung nodules are being incidentally discovered. […] Read more
PET vs. CT in Lung Cancer Surveillance: The ‘Pro’ Side from the Nuclear Medicine Perspective
Asha Kandathil, MDA significant proportion of patients with stage I to III NSCLC or SCLC will have locoregional or distant metastases following curative-intent therapy. Studies have reported local recurrence rates of 22% […] Read more
Program Trains Patient Research Advocates to be STARS
Lauren Evoy DavisWhat does it take to become a star in any setting? Passion, knowledge, and drive. When it comes to understanding the science of lung cancer, sometimes the experts are the […] Read more
In 2020 the U.S. Food and Drug Administration (FDA) launched Project Patient Voice, an online platform for patients and caregivers along with their health care providers to look at patient-reported […] Read more
FDA Perspectives on the Use of Liquid Biopsy in NSCLC
Kara Nyberg, PhDThe US Food and Drug Administration (FDA) recognizes the value of liquid biopsy in managing patients with cancer, and the agency is actively working to bring these assays to the clinic. Harpreet Singh, MD, Director of […] Read more
Multidisciplinary Tumor Board: A Single Institution’s Perspective
Ari Rosenberg, MDAs 7:00 AM approaches, the ninth-floor conference room slowly fills as team members fi le in and find their seats. The senior radiation oncologist identifies his seat in the front row, carefully placing his stack […] Read more
Multidisciplinary Tumor Board: A Single Institution’s Perspective
By Ari Rosenberg, MD Posted: June 24, 2020 As 7:00 AM approaches, the ninth-floor conference room slowly fills as team members file in and find their seats. The senior […] Read more
Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous
By Mary Jo Fidler, MD Posted: June 10, 2020 Healthcare systems in the United States have been slow to adopt telehealth, in part, due to regulatory limitations, patient privacy […] Read more
Making Mesothelioma Patient Research Happen: The United Kingdom Experience
By Liz Darlison, MBE, EN, RN, BSc, MSc; Clare Gardiner, PhD, BSc (hons); Catherine Henshall, MN, RN, MA, PhD; and Angela M. Tod, PhD, MSc, MMedSci, BA (hons), RN Posted: […] Read more